About us

Bjørn Olav Selbekk
CEO

• Selbekk Consulting
  Sales strategy and professional sales training including "train the trainer". Strategic and marketing consulting. Launch and business plans (Country and Nordic) Leadership development and coaching.
• Associate ASK Global Consultancy, United Kingdom
  We are experts in designing and delivering solutions for the pharmaceutical industry. We believe that all companies have pockets of excellence within. Our aim is to highlight these and make the most of them.We enable real understanding by asking targeted questions, allowing us to gain deep insights and deliver bespoke solutions to maximize strategic effectiveness and competitive performance.
• Nordic Sales Manager, Rare Diseases at Shire Pharmaceuticals, Sweden
• Consultant and Product Manager HAE, Shire HGT
  Relaunch and development of brand and sales strategy. Advising repossession and market penetration resulting in the best sales performance pr.capita in Europe. European Performance Award 2012. Sales coaching/mentoring in Scandinavia.
• Business Unit Manager Oncology and Infection AstraZeneca
• Marketing Manager Oncology and CNS AstraZeneca
• Manager sales development and training, AstraZeneca

Kjetil Herland
Partner

• Chairman of the board, Birk NPC AS
  
• Director of the Board, 1hjelp.no AS
• Managing Director Nordic, Nigaard Pharma AS
• Member Board of Directors, Nigaard Pharma AS
• CEO and Gründer, Nigaard Pharma AS
  Build up a full service pharmaceutical company in the Nordics and sold this out in 2015.
  a pharma company specialied in CF, non-CF bronchiectasis and allergy in the Nordic countries, including Iceland
• Owner and Gründer, Herland AS
  CRO, respiratory specialist company
• CRA/CRM, AstraZeneca
  
• Product Group Manager, AstraZeneca
• Product Manager Pulmicort, AstraZeneca
  Launched Pulmicort (astma) in Norway , 1. pharmaceutical in Norway who sold for more than 11 mill EURO /year
• Sales rep, AstraZeneca
  MA share of 70% Pulmicort Turbuhaler in one year
  

Publications

How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med. 2005 Jan;99(1):11-9. January 15, 2005

Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. Respir Med. 2001 Jul;95(7):571-6. July 15, 2001